Inotiv, Inc. Common Stock earnings per share and revenue
On Dec 03, 2025, NOTV reported earnings of -0.25 USD per share (EPS) for Q4 25, beating the estimate of -0.46 USD, resulting in a 46.72% surprise. Revenue reached 138.14 million, compared to an expected 138.32 million, with a -0.13% difference. The market reacted with a -6.53% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.65 USD, with revenue projected to reach 123.33 million USD, implying an increase of 160.00% EPS, and decrease of -10.72% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
What were Inotiv, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Inotiv, Inc. Common Stock reported EPS of -$0.25, beating estimates by 46.72%, and revenue of $138.14M, -0.13% below expectations.
How did the market react to Inotiv, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -6.53%, changed from $0.94 before the earnings release to $0.88 the day after.
When is Inotiv, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 09, 2026.
What are the forecasts for Inotiv, Inc. Common Stock's next earnings report?
Based on 5
analysts, Inotiv, Inc. Common Stock is expected to report EPS of -$0.65 and revenue of $123.33M for Q1 2026.